Sort
51,593 grants matching “hepatitis”
UCSF Liver Core Center
$1,100,000Jacquelyn J. Maher · University Of California, San Francisco · P30 · FY2009 · DK
Innate immunity and cytokines in liver diseases
$1,096,687Bin Gao · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2011 · AA
Optimizing combination therapy for Hepatitis C virus with pharmacodynamic models
$1,096,497Ashley Brown · University Of Florida · R01 · FY2018 · AI
Molecular Subtypes for Targeted Therapies in Alcoholic Hepatitis
$1,096,295Ramon Bataller · Univ Of North Carolina Chapel Hill · U01 · FY2014 · AA
Tracking HIV Infection & Alcohol Abuse CNS Comorbidity with Neuroimaging
$1,096,151Adolf Pfefferbaum · Sri International · R01 · FY2022 · AA
DCTD Human Toxicology and Pharmacology
$1,095,585David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2014 · CA
Motivational enhancement to augment contingency management for SARS-CoV-2 testing and vaccination utilization among syringe exchange clients
$1,095,176Anne Marie Mauricio · University Of Oregon · U01 · FY2022 · DA
Primary Cilia: A Novel Signaling Gateway To Neural Circuit Modulation
$1,094,968Eva S Anton · Univ Of North Carolina Chapel Hill · R01 · FY2024 · MH
Primary Cilia: A Novel Signaling Gateway To Neural Circuit Modulation
$1,094,968Eva S Anton · Univ Of North Carolina Chapel Hill · R01 · FY2023 · MH
Xenobiotic-Metabolizing Enzymes
$1,094,579Frank J Gonzalez · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Xenobiotic Receptors
$1,094,579Frank J Gonzalez · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Small Molecule Therapeutics for Renal Disease
$1,094,052Prakash Narayan · Angion Biomedica Corporation · R44 · FY2010 · DK
San Francisco Bay Clinical Trials Unit (CTU)
$1,093,620Susan Buchbinder · Public Health Foundation Enterprises · UM1 · FY2025 · AI
Water Contaminants and Cardiovascular Risk: the Jackson Heart Study
$1,093,506April P Carson · University Of Mississippi Med Ctr · R01 · FY2024 · HL
ASIAN AMERICAN NETWORK FOR CANCER AWAREN. RESEARCH &TRG
$1,093,389University Of California Davis · U01 · FY2005 · CA
Neural Circuits, Kinetics and Energetics HTS of Human iPSC-Neurons, -Microglia, and -Astrocytes: AI-Enabled Platform for Target ID, and Drug Discovery and Toxicity (e.g., Cancer Chemo & HIV ARTs)
$1,092,964Jeffrey H. Price · Vala Sciences, Inc. · R44 · FY2025 · MH
Childhood Liver Disease Research Network Data Coordinating Center
$1,092,450John C Magee · University Of Michigan At Ann Arbor · U24 · FY2019 · DK
Incidence of HIV Infection in a Cohort of IV Drug Users
$1,090,420Shruti H Mehta · Johns Hopkins University · R01 · FY2009 · DA
Multidisciplinary Studies of Lymphoma
$1,089,881Patricia Hartge · Cancer Epidemiology And Genetics · Z01 · FY2007 · CA
ACCELERATION OF HEPATIC FIBROSIS BY ALCOHOL: ROLE OF ADENOSINE
$1,089,345The Cleveland Clinic Foundation · · FY2010 · Department of the Army
Optimizing SWELL1 modulators to treat non-alcoholic steatohepatitis
$1,089,280Daniel J Lerner · Senseion Therapeutics, Inc. · R44 · FY2022 · DK
Discrimination of nonself by innate immune receptors
$1,088,811Joseph Marcotrigiano · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Entry and replication of positive-sense, RNA viruses
$1,088,811Joseph Marcotrigiano · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Tracking HIV Infection & Alcohol Abuse CNS Comorbidity with Neuroimaging
$1,088,145Adolf Pfefferbaum · Sri International · U01 · FY2021 · AA
Safety & Eff Evals of TM/BP Prod in Repeat Low-Dose Macaque SIV/SHIV Infec Models
$1,087,363National Institute Of Allergy And Infectious Diseases · Y01 · FY2010 · AI